# Stille > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/stille). ## Overview Stille is a Swedish medical technology company that designs, manufactures, and sells premium surgical instruments and surgical tables. Its business is organized around specialized products for operating rooms, with production and commercial presence in Sweden and several international markets. ## Products & services • Surgical instruments for specialized procedures • Surgical tables and operating tables • ImagiQ3 imaging-compatible surgical table systems • Sales, service, and assembly support • R&D and product development for niche surgical tools - **Surgical Instruments** (72%) — Premium hand-held and specialty instruments used in operating rooms. - **Surgical Tables** (28%) — Operating tables and table systems for image-guided and general surgery. - Surgical instruments for specialized procedures - Surgical tables and operating tables - ImagiQ3 imaging-compatible surgical table systems - Sales, service, and assembly support - R&D and product development for niche surgical tools ## Customers Stille sells primarily to hospitals, surgical centers, and healthcare providers that need specialized operating-room equipment. Its products are also purchased through distributors and strategic partners that serve surgeons and medical institutions in multiple countries. Demand is tied to procedure volumes, replacement cycles, and the need for high-quality instruments and tables in niche surgical specialties. - **Hospitals and surgical departments** (primary) — Buy surgical instruments and tables for operating rooms and specialty procedures. - **Distributors and strategic partners** (primary) — Purchase and resell Stille products to extend geographic reach and market access. - **Surgeons and clinical specialists** (secondary) — Influence product selection based on precision, quality, and workflow fit. - **Healthcare systems and clinics** (secondary) — Buy replacement and upgrade equipment for specialized surgical use. - Hospitals and surgical departments buying operating-room equipment - Distributors and strategic partners expanding market reach - Surgeons and clinical teams needing precision instruments - Healthcare providers replacing or upgrading specialty tables - Institutions in niche specialties such as cardiovascular and neuro surgery ## Geography Stille is headquartered in Torshälla, Sweden, where it also has sales, R&D, and production. The company also operates from Germany, Switzerland, the UK, the US, and the UAE, with sales, service, assembly, and production activities supporting international distribution. - **Sweden** — Core operating base and production site - **Europe** — Key commercial and production footprint across Europe - **North America** — Sales and assembly presence in the United States - **Middle East** — Regional sales presence via Dubai - Head office, R&D, and production in Torshälla, Sweden - Sales and R&D presence in Germany and Switzerland - Sales and assembly operations in Chicago, US - Sales, service, and production in Southend-on-Sea, UK - Sales presence in Dubai, UAE for regional market access ## Strategy Stille’s strategy centers on premium product leadership, sales expansion through strategic partners, operational excellence, and acquisitions. The company aims to deepen its position in niche clinical segments where product quality, brand reputation, and distribution reach are important competitive advantages. - **Premium product leadership** (medium-term) — Supports pricing power and differentiation in specialized surgical niches. - **Sales expansion through partners** (short-term) — Extends market reach without relying only on direct sales. - **Operational excellence** (short-term) — Improves delivery reliability, lead times, and manufacturing scalability. - **Acquisitions** (medium-term) — Adds products, brands, and channels that broaden the portfolio. - Focus on premium products for niche clinical segments - Expand sales through strategic partners and direct channels - Improve operational efficiency and manufacturing capacity - Use acquisitions to add products and distribution reach - Invest in R&D to support product leadership and differentiation ## Risks Stille is exposed to supply-chain disruption, currency movements, and demand variability in hospital purchasing cycles. As a medical device company, it also faces product quality, regulatory, and competitive risks, while acquisitions add integration and valuation uncertainty. - **Supply-chain and component shortages** [high] — Specialty instruments and tables depend on timely supplier deliveries and critical parts. - **Foreign exchange exposure** [medium] — International sales and sourcing create USD and EUR translation and transaction effects. - **Customer investment cycle volatility** [medium] — Hospitals may delay capital purchases and replacement orders. - **Product safety and field corrective actions** [high] — Medical devices can require remediation if performance or safety issues arise. - **Acquisition integration and earnout risk** [medium] — Purchased businesses can create integration complexity and contingent liabilities. - Supply-chain constraints can delay deliveries and limit sales - USD and EUR movements affect pricing and margins - Hospital investment cycles can shift demand timing - Product quality or safety issues can disrupt table sales - Acquisitions create integration and valuation risk ## Accounting Stille’s reporting is affected by acquisition accounting, including goodwill, brands, customer relationships, and contingent consideration from acquired businesses. Currency hedges, intangible asset amortization, and impairment testing are important because they can materially affect reported earnings and balance-sheet values. - **Business combination accounting** — Affects balance sheet, amortization, and future impairment risk - **Intangible asset useful lives** — Impacts operating profit and comparability over time - **Goodwill and brand impairment** — Could create non-cash charges - **Hedge accounting for USD and EUR flows** — Affects reported financial items and equity reserves - **Contingent consideration / earnouts** — Can change liabilities and profit or loss - Acquisition accounting creates goodwill and intangible assets - Customer relationships are amortized over long useful lives - Brands may be indefinite-lived and tested for impairment - USD and EUR hedges affect financial income and equity - Earnout liabilities require valuation and remeasurement --- *Last updated: 2026-08-11T04:04:55.978509+00:00*